ANAB vs INCY · rev $234.6M vs P/E 14, rev $5.14B
AnaptysBio Inc (ANAB) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
ANAB currently screens at market cap $1.62B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the ANAB and INCY stock pages for the full models.
Not investment advice.